Aprea Therapeutics Inc (APRE)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.91M
Last updated: Nov 17, 2026 at 11:02 AM ET
Aprea Therapeutics Inc (APRE) Competitors
The companies most similar to Aprea Therapeutics are Processa Pharmaceuticals (PCSA), Tempest Therapeutics (TPST) and Traws Pharma (TRAW). By market cap, Aprea Therapeutics ranks 7th of the 13 companies on this page; Phio Pharmaceuticals (PHIO) is the largest at $9.21M.
Peer Comparison
APRE's revenue growth of -98.4% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Aprea Therapeutics (APRE) | $5.91M | N/A | N/A | 0.0% | N/A | -98.4% | 0.00% |
| Processa Pharmaceuticals Inc (PCSA) | $5.20M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tempest Therapeutics Inc (TPST) | $7.64M | N/A | N/A | 0.0% | -783.6% | 0.0% | 0.00% |
| Traws Pharma Inc (TRAW) | $3.86M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Azitra Inc (AZTR) | $3.69M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Alaunos Therapeutics Inc (TCRT) | $6.86M | N/A | N/A | 0.0% | N/A | -25.0% | 0.00% |
| Lantern Pharma Inc (LTRN) | $6.47M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Theriva Biologics Inc. (TOVX) | $6.61M | N/A | 21.5x | 0.0% | -52.3% | 0.0% | 0.00% |
| Phio Pharmaceuticals Corp (PHIO) | $9.21M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Moleculin Biotech Inc (MBRX) | $8.02M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| PharmaCyte Biotech Inc (PMCB) | $3.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | $4.02M | N/A | N/A | 0.0% | -247.2% | 0.0% | 0.00% |
| Pulmatrix Inc (PULM) | $4.71M | N/A | N/A | 0.0% | N/A | -99.9% | 0.00% |
| Peer median | $5.84M | N/A | 21.5x | 0.0% | -247.2% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Aprea Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Processa Pharmaceuticals Inc (PCSA) | Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of patients... | PCSA competitors |
| Tempest Therapeutics Inc (TPST) | Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated... | TPST competitors |
| Traws Pharma Inc (TRAW) | Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States. | TRAW competitors |
| Azitra Inc (AZTR) | Azitra Inc, a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live... | AZTR competitors |
| Alaunos Therapeutics Inc (TCRT) | Alaunos Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on discovering, acquiring... | TCRT competitors |
| Lantern Pharma Inc (LTRN) | Lantern Pharma Inc., a clinical-stage biotechnology company, focuses on developing precision cancer therapies using artificial intelligence, genomics... | LTRN competitors |
| Theriva Biologics Inc. (TOVX) | Theriva Biologics Inc., a clinical-stage company, develops therapies to treat diseases in areas of high unmet need. | TOVX competitors |
| Phio Pharmaceuticals Corp (PHIO) | Phio Pharmaceuticals Corp. The company is headquartered in Marlborough, Massachusetts. | PHIO competitors |
| Moleculin Biotech Inc (MBRX) | Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of cancer drug candidates for the treatment of highly resistant... | MBRX competitors |
| PharmaCyte Biotech Inc (PMCB) | PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United... | PMCB competitors |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California. | LIMN competitors |
| Pulmatrix Inc (PULM) | Pulmatrix, Inc., a clinical-stage biopharmaceutical company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases... | PULM competitors |
Frequently Asked Questions About APRE
Who are Aprea Therapeutics' main competitors?
The companies most similar to Aprea Therapeutics include Processa Pharmaceuticals (PCSA), Tempest Therapeutics (TPST), Traws Pharma (TRAW), Azitra (AZTR) and Alaunos Therapeutics (TCRT), listed from the closest match.
Who is Aprea Therapeutics' biggest competitor?
Phio Pharmaceuticals (PHIO) is the largest of the similar companies at $9.21M; Processa Pharmaceuticals (PCSA) is the closest match by business profile, size, sector and industry.
How does APRE stock compare with its competitors?
APRE's net margin is 0.0% against a peer median of 0.0%.
Which of Aprea Therapeutics' competitors pays a higher dividend?
Aprea Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Aprea Therapeutics bigger than its competitors?
No. Aprea Therapeutics is 7th by market cap among the 13 companies on this page; the largest is Phio Pharmaceuticals (PHIO) at $9.21M.
APRE pages: Overview, Earnings, Forecast, Financials, Competitors